Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Manufacturer of Popular Herbicide Intensifies Legal Battle Against Cancer-Linked Lawsuits

Reading Time: < 1 minute

Global chemical manufacturer Bayer is ramping up its efforts to shield itself from a wave of lawsuits alleging its popular weedkiller, Roundup, can cause cancer. Despite setting aside $16 billion to settle around 170,000 cases, Bayer is now turning to state lawmakers for relief.

Bayer’s lobbying efforts in Missouri, Iowa, and Idaho this year aimed to block legal arguments against the company, but ultimately failed in all three states. Undeterred, Bayer plans to push for protective legislation during next year’s legislative sessions and may expand its efforts to other states.

The lawsuits against Bayer allege that Roundup’s key ingredient, glyphosate, can cause non-Hodgkin lymphoma. While some studies have linked glyphosate to cancer, the U.S. Environmental Protection Agency maintains that it is not likely to be carcinogenic when used as directed.

Bayer’s push for protective legislation would shield pesticide companies from claims related to cancer warnings if their products comply with EPA regulations. Some lawmakers fear that if the lawsuits continue, Bayer may pull Roundup from the U.S. market, potentially forcing farmers to seek alternatives from China.

Despite facing setbacks in state legislatures, Bayer remains committed to its efforts to protect itself from the onslaught of lawsuits. The company’s future actions regarding Roundup remain uncertain, but the stakes are high as it navigates a complex legal landscape while continuing to face pressure from the agriculture industry.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money